BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26837701)

  • 1. Consensus statement from the International Radiosurgery Oncology Consortium for Kidney for primary renal cell carcinoma.
    Siva S; Ellis RJ; Ponsky L; Teh BS; Mahadevan A; Muacevic A; Staehler M; Onishi H; Wersall P; Nomiya T; Lo SS
    Future Oncol; 2016 Mar; 12(5):637-45. PubMed ID: 26837701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma: A report from the International Radiosurgery Oncology Consortium for Kidney (IROCK).
    Siva S; Louie AV; Warner A; Muacevic A; Gandhidasan S; Ponsky L; Ellis R; Kaplan I; Mahadevan A; Chu W; Swaminath A; Onishi H; Teh B; Correa RJ; Lo SS; Staehler M
    Cancer; 2018 Mar; 124(5):934-942. PubMed ID: 29266183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survey of current practices from the International Stereotactic Body Radiotherapy Consortium (ISBRTC) for head and neck cancers.
    Karam I; Yao M; Heron DE; Poon I; Koyfman SA; Yom SS; Siddiqui F; Lartigau E; Cengiz M; Yamazaki H; Hara W; Phan J; Vargo JA; Lee V; Foote RL; Harter KW; Lee NY; Sahgal A; Lo SS
    Future Oncol; 2017 Mar; 13(7):603-613. PubMed ID: 27842456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of epidural progression following postoperative spine stereotactic body radiotherapy: implications for clinical target volume delineation.
    Chan MW; Thibault I; Atenafu EG; Yu E; John Cho BC; Letourneau D; Lee Y; Yee A; Fehlings MG; Sahgal A
    J Neurosurg Spine; 2016 Apr; 24(4):652-9. PubMed ID: 26682603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic ablative body radiation therapy for primary kidney cancer: a 3-dimensional conformal technique associated with low rates of early toxicity.
    Pham D; Thompson A; Kron T; Foroudi F; Kolsky MS; Devereux T; Lim A; Siva S
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1061-8. PubMed ID: 25442039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic ablative body radiotherapy for primary kidney cancer: what have we learned from prospective trials and what does the future hold?
    Siva S; Daniels CP; Ellis RJ; Ponsky L; Lo SS
    Future Oncol; 2016 Mar; 12(5):601-6. PubMed ID: 26837548
    [No Abstract]   [Full Text] [Related]  

  • 7. Vertebral compression fractures after stereotactic body radiation therapy: a large, multi-institutional, multinational evaluation.
    Jawad MS; Fahim DK; Gerszten PC; Flickinger JC; Sahgal A; Grills IS; Sheehan J; Kersh R; Shin J; Oh K; Mantel F; Guckenberger M;
    J Neurosurg Spine; 2016 Jun; 24(6):928-36. PubMed ID: 26895526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic body radiotherapy for renal cell cancer and pancreatic cancer : Literature review and practice recommendations of the DEGRO Working Group on Stereotactic Radiotherapy.
    Panje C; Andratschke N; Brunner TB; Niyazi M; Guckenberger M
    Strahlenther Onkol; 2016 Dec; 192(12):875-885. PubMed ID: 27778052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-fraction versus multifraction spinal stereotactic radiosurgery for spinal metastases from renal cell carcinoma: secondary analysis of Phase I/II trials.
    Ghia AJ; Chang EL; Bishop AJ; Pan HY; Boehling NS; Amini B; Allen PK; Li J; Rhines LD; Tannir NM; Tatsui CE; Brown PD; Yang JN
    J Neurosurg Spine; 2016 May; 24(5):829-36. PubMed ID: 26799117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review of stereotactic radiotherapy ablation for primary renal cell carcinoma.
    Siva S; Pham D; Gill S; Corcoran NM; Foroudi F
    BJU Int; 2012 Dec; 110(11 Pt B):E737-43. PubMed ID: 23107102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of spinal metastases from renal cell carcinoma using stereotactic body radiotherapy.
    Nguyen QN; Shiu AS; Rhines LD; Wang H; Allen PK; Wang XS; Chang EL
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1185-92. PubMed ID: 19632064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Spinal stereotactic body radiotherapy: French assessment in 2016].
    Pougnet I; Jaegle E; Garcia R; Tessier F; Faivre JC; Louvel G; Gross E; Gonzague L; Benchalal M; Ducteil A; Supiot S; Autret D; Clavier JB; Mirabel X; Bellière A; Wdowczyk D; Heymann S; Barillot I; de La Lande B; Passerat V; Sunyach MP; Lipinski F; Thibouw D; Guichard F; Chauvet B; Thariat J; Arnaud A
    Cancer Radiother; 2017 Jun; 21(4):276-285. PubMed ID: 28499659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic body radiotherapy for primary renal cell carcinoma: a systematic review and practice guideline from the International Society of Stereotactic Radiosurgery (ISRS).
    Siva S; Louie AV; Kotecha R; Barber MN; Ali M; Zhang Z; Guckenberger M; Kim MS; Scorsetti M; Tree AC; Slotman BJ; Sahgal A; Lo SS
    Lancet Oncol; 2024 Jan; 25(1):e18-e28. PubMed ID: 38181809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spine stereotactic body radiotherapy for renal cell cancer spinal metastases: analysis of outcomes and risk of vertebral compression fracture.
    Thibault I; Al-Omair A; Masucci GL; Masson-Côté L; Lochray F; Korol R; Cheng L; Xu W; Yee A; Fehlings MG; Bjarnason GA; Sahgal A
    J Neurosurg Spine; 2014 Nov; 21(5):711-8. PubMed ID: 25170656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of different breathing patterns in the same patient on stereotactic ablative body radiotherapy dosimetry for primary renal cell carcinoma: a case study.
    Pham D; Kron T; Foroudi F; Siva S
    Med Dosim; 2013; 38(3):304-8. PubMed ID: 23582701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of stereotactic radiotherapy on kidney function in primary renal cell carcinoma: Establishing a dose-response relationship.
    Siva S; Jackson P; Kron T; Bressel M; Lau E; Hofman M; Shaw M; Chander S; Pham D; Lawrentschuk N; Wong LM; Goad J; Foroudi F
    Radiother Oncol; 2016 Mar; 118(3):540-6. PubMed ID: 26873790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Commentary on "A systematic review of stereotactic radiotherapy ablation for primary renal cell carcinoma." Siva S, Pham D, Gill S, Corcoran NM, Foroudi F. Division of Radiation Oncology and Cancer Imaging, Peter MacCallum Cancer Centre, Victoria, Australia.: BJU Int 2012;110(11 Pt B):E737-43. doi: 10.1111/j.1464-410X.2012.11550.x. [Epub 2012 Oct 29].
    Gottschalk A
    Urol Oncol; 2014 Apr; 32(3):374-5. PubMed ID: 24679465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns-of-care for thoracic stereotactic body radiotherapy among practicing radiation oncologists in the United States.
    Daly ME; Perks JR; Chen AM
    J Thorac Oncol; 2013 Feb; 8(2):202-7. PubMed ID: 23222368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CyberKnife for inoperable renal tumors: Canadian pioneering experience.
    Nair VJ; Szanto J; Vandervoort E; Cagiannos I; Breau R; Malone C; Avruch L; Pantarotto J; Malone S
    Can J Urol; 2013 Oct; 20(5):6944-9. PubMed ID: 24128835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic Radiotherapy as a Treatment Option for Renal Tumors in the Solitary Kidney: A Multicenter Analysis from the IROCK.
    Correa RJM; Louie AV; Staehler M; Warner A; Gandhidasan S; Ponsky L; Ellis R; Kaplan I; Mahadevan A; Chu W; Swaminath A; Onishi H; Teh BS; Lo SS; Muacevic A; Siva S
    J Urol; 2019 Jun; 201(6):1097-1104. PubMed ID: 30741849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.